PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - April 25, 2016) - MolecularMD Corp., a molecular diagnostics company that accelerates oncology drug development by providing custom companion diagnostic ...

PORTLAND, Ore. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- MolecularMD Corp. and ARIAD Pharmaceuticals, Inc. (NAS: ARIA) today announced that MolecularMD has voluntarily withdrawn its Premarketing Approval ...

PORTLAND, OR--(Marketwired - Apr 4, 2013) - Today MolecularMD Corp. announced the launch of its next generation sequencing (NGS) services designed to support MolecularMD's pharmaceutical and ...

FRANKLIN LAKES, N.J. and PORTLAND, Ore., June 2, 2011 /PRNewswire/ -- Medco Health Solutions, Inc. (NYSE: MHS) and MolecularMD Corp. today announce the launch of a personalized medicine program for ...

PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - Jun 12, 2014) - MolecularMD Corp., a molecular diagnostics company that provides custom companion diagnostic solutions and supporting clinical trial ...

Ballast Point Ventures, a St. Petersburg, Fla., firm affiliated with Raymond James Financial, Inc. closed a $3 million growth equity investment in MolecularMD Corporation, a West Palm Beach, Fla., ...

--Asterand Bioscience, the leader in high quality, well-characterized human tissue and human tissue-based research solutions supporting drug discovery and development, announced today a partnership ...

Personal Genome Diagnostics (PGDx) is teaming up with MolecularMD to market a suite of personalized medicine services to cancer researchers and drug developers. The collaboration is designed to ...

PORTLAND, OR--(Marketwire - Oct 24, 2012) - MolecularMD Corp. announced today that presentations pertaining to clinical validation of Next Generation Sequencing platforms and advances in non-invasive ...

PORTLAND, OR and CAMBRIDGE, MA--(Marketwired - June 01, 2017) - MolecularMD Corp., a molecular diagnostics company that provides clinical trial services and development of companion diagnostics for ...